This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Pacific Meinuoke Bio-Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Xiaochun Chen: Innovator in Pharmaceutical Preparations
Introduction
Xiaochun Chen is a notable inventor based in Changzhou, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. Her work focuses on innovative solutions for treating serious health conditions.
Latest Patents
Xiaochun Chen holds a patent for a pharmaceutical preparation that stably comprises a CD147 monoclonal antibody. This preparation includes a buffer, a protein protectant, and a surfactant. The formulation is designed to maintain the stability of the CD147 monoclonal antibody over an extended period. Additionally, the patent outlines the use of this pharmaceutical preparation in creating drugs for treating CD147-related diseases, especially non-small cell lung cancer.
Career Highlights
Xiaochun Chen is associated with Jiangsu Pacific Meinuoke Bio-Pharmaceutical Co., Ltd., where she applies her expertise in pharmaceutical development. Her innovative approach has led to advancements in drug stability and efficacy.
Collaborations
Xiaochun collaborates with talented professionals in her field, including Hao Tang and Qiang Feng. These partnerships enhance the research and development efforts at her company.
Conclusion
Xiaochun Chen's contributions to pharmaceutical preparations demonstrate her commitment to advancing medical science. Her innovative work in drug formulation is paving the way for effective treatments for serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile